A Phase I/II Study of Twice Weekly Ixazomib Plus Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma
Nadeem, Omar, Redd, Robert A., Bayliss, Trevor J., Barth, Peter, Laubach, Jacob, Mo, Clifton C., Bianchi, Giada, Masone, Kelly, Griffin, Kyle, Issokson, Lindsay, Barrell, Anna, Doherty, Randi, Mailand, Deborah, Distaso, Alexandra, Patches, Sarah, Goodrich, Kathryn, Oneill, Kathleen, Sanchorawala, Vaishali, Shune, Leyla O., Richardson, Paul G.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article